HRAS, HRas proto-oncogene, GTPase, 3265
N. diseases: 698; N. variants: 29
Source: ALL
Disease | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
0.540 | GeneticVariation | disease | BEFREE | To our knowledge this is the first described case of PPK in which the existence of an HRAS mosaic mutation is the confirmed cause of rhabdomyosarcoma. | 29430633 | 2018 | ||||
|
0.540 | GeneticVariation | disease | BEFREE | This case expands our knowledge of the genetic basis for phacomatosis, in which mutations in HRAS have been previously described, although this report provides evidence that activating mutations in KRAS or HRAS may cause PPK. | 28523882 | 2017 | ||||
|
0.540 | GeneticVariation | disease | BEFREE | Combined melanocytic and sweat gland neoplasm: cell subsets harbor an identical HRAS mutation in phacomatosis pigmentokeratotica. | 24628623 | 2014 | ||||
|
0.540 | Biomarker | disease | GENOMICS_ENGLAND | Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia. | 24006476 | 2014 | ||||
|
0.540 | GeneticVariation | disease | BEFREE | Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell. | 23337891 | 2013 | ||||
|
0.540 | SomaticCausalMutation | disease | ORPHANET | Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell. | 23337891 | 2013 | ||||
|
0.540 | Biomarker | disease | GENOMICS_ENGLAND | Germline mutations in HRAS proto-oncogene cause Costello syndrome. | 16170316 | 2005 | ||||
|
0.540 | Biomarker | disease | GENOMICS_ENGLAND |